Evidence map›Paper›PMID 41097807›Full record

ArticleCancers2025

Correction: Rodríguez-Bautista et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior.

Rubén Rodríguez-Bautista, Claudia H Caro-Sánchez, Paula Cabrera-Galeana, Gerardo J Alanis-Funes, Everardo Gutierrez-Millán, Santiago Ávila-Ríos, Margarita Matías-Florentino, Gustavo Reyes-Terán, José Díaz-Chávez, Cynthia Villarreal-Garza and 5 more

Abstract readPublished Erratum
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Rubén Rodríguez-BautistaLaboratorio de Medicina Personalizada de la Unidad de Oncología Torácica, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.
Claudia H Caro-SánchezDepartmento de Patología, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.
Paula Cabrera-GaleanaDepartamento de Oncología Médica-Tumores Mamarios, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.
Gerardo J Alanis-FunesBio Assisted Sequencing Environment National Sequencing Laboratory (Tec-BASE), School of Engineering and Sciences, Tecnologico de Monterrey, Monterrey 64849, Mexico.ORCID 0000-0003-1895-6193
Everardo Gutierrez-MillánCentro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.
Santiago Ávila-RíosCentro de Investigación de Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias, Mexico City 14080, Mexico.
Margarita Matías-FlorentinoCentro de Investigación de Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias, Mexico City 14080, Mexico.
Gustavo Reyes-TeránCentro de Investigación de Enfermedades Infecciosas, Instituto Nacional de Enfermedades Respiratorias, Mexico City 14080, Mexico.
José Díaz-ChávezUnidad de Investigación Biomédica en Cáncer, INCan-Instituto de Investigaciones Biomédicas, UNAM, Mexico City 14080, Mexico.
Cynthia Villarreal-GarzaDepartamento de Oncología Médica-Tumores Mamarios, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.
Norma Y Hernández-PedroLaboratorio de Medicina Personalizada de la Unidad de Oncología Torácica, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.ORCID 0000-0003-1630-8440
Alette Ortega-GómezLaboratorio de Medicina Traslacional, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.
Luis Lara-MejíaThoracic Oncology Unit, Department of Thoracic Oncology, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.
Claudia Rangel-EscareñoSchool of Engineering and Sciences, Tecnologico de Monterrey, Epigmenio González 500, San Pablo, Santiago de Querétaro 76130, Mexico.
Oscar ArrietaLaboratorio de Medicina Personalizada de la Unidad de Oncología Torácica, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.ORCID 0000-0002-1164-3779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A Fine-Gray analysis was missing in the original version [...].

Identifiers

PMID41097807
PMCPMC12524062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.